USP13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.12083733592317E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.46470013474254E-10 |
Normal-vs-Stage2 |
3.12369996535722E-09 |
Normal-vs-Stage3 |
2.35866881581615E-12 |
Normal-vs-Stage4 |
1.20990000240795E-08 |
Stage1-vs-Stage2 |
1.950170E-01 |
Stage1-vs-Stage3 |
5.597800E-02 |
Stage1-vs-Stage4 |
4.198400E-01 |
Stage2-vs-Stage3 |
9.100000E-01 |
Stage2-vs-Stage4 |
5.781800E-01 |
Stage3-vs-Stage4 |
4.223400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.0258018313134E-12 |
Normal-vs-AfricanAmerican |
2.040500E-04 |
Normal-vs-Asian |
4.238900E-03 |
Caucasian-vs-AfricanAmerican |
7.218800E-01 |
Caucasian-vs-Asian |
9.086600E-01 |
AfricanAmerican-vs-Asian |
7.092200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.66637880850385E-12 |
Normal-vs-Female |
2.4533000075877E-09 |
Male-vs-Female |
5.339800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.982100E-04 |
Normal-vs-Age(41-60Yrs) |
9.1745000485588E-09 |
Normal-vs-Age(61-80Yrs) |
1.62492241884138E-12 |
Normal-vs-Age(81-100Yrs) |
6.71000000007638E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.906800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.004180E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.294390E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.521620E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.815250E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.588200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.021600E-01 |
Normal-vs-Grade 2 |
6.65459998216988E-09 |
Normal-vs-Grade 3 |
1.79423143009672E-12 |
Normal-vs-Grade 4 |
3.01970004557006E-09 |
Grade 1-vs-Grade 2 |
1.611620E-01 |
Grade 1-vs-Grade 3 |
6.731900E-02 |
Grade 1-vs-Grade 4 |
9.581800E-02 |
Grade 2-vs-Grade 3 |
1.110040E-02 |
Grade 2-vs-Grade 4 |
2.308200E-01 |
Grade 3-vs-Grade 4 |
5.082200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.32360044935842E-10 |
Normal-vs-ccB subtype |
3.75479647374277E-11 |
ccA subtype-vs-ccB subtype |
4.166400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.44979608715812E-11 |
Normal-vs-N1 |
2.077600E-02 |
N0-vs-N1 |
2.507600E-01 |
|
|